Drug resistant infections cause 700,000 deaths per year; this number could rise to 10 million by 2050 unless urgent action is taken. Investing in immunisation limits the spread of pathogens around the world and reduces the reliance on, and cost of, antibiotics. Vaccines must be considered a fundamental element in AMR prevention, preparedness and response. Increasing coverage of vaccines, research and development into new vaccines and vaccine delivery systems are central to this.
The panel discussion event will discuss the findings of the Wellcome Trust’s report ‘Vaccines to tackle drug-resistant infections’.
Secretary of State for the Department of Health and Social Care, Matthew Hancock MP, will give special remarks.
- Dr Philippa Whitford MP, Chair of APPG Vaccinations for All
- Julian Sturdy MP, Chair of the APPG Antibiotics
- Nick Adkin, Deputy Director of Global Health Security, DHSC
- Wilson Mok, Head of Policy, Gavi, the Vaccine Alliance
- Dr Marc Sprenger, Director of AMR Secretariat, WHO
- Dr Padmini Srikantiah, Senior Programme Officer Global Health, The Bill and Melinda Gates Foundation
- Dr Bryan Deane, New Medicines & Data Policy Director, Association of British Pharmaceutical Industry (ABPI)
For more information, please contact email@example.com.